Search - tctmd.com

June 01, 2021

News Daily News

Add-on CMS Payment Sweetens Shockwave Choice, but Cost Still Rankles

May 12, 2021

News Conference News ACC 2021

Prediabetes Linked to Higher MACE Risk

Todd Neale

May 10, 2021

News Conference News SCAI 2021

Better Success With Next-Generation Robotic PCI: PRECISION GRX

April 30, 2021

News Daily News

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

April 21, 2021

News Daily News

Meta-analysis Affirms Colchicine’s Myriad CV Benefits

April 12, 2021

News Daily News

Papers Confirm Rare Thrombocytopenia Link to AstraZeneca Vaccine

Shelley Wood

April 09, 2021

News CV Team Pro

Emily Fussman

March 30, 2021

News Daily News

Pills for Erectile Dysfunction Linked to Fewer CVD Deaths

March 24, 2021

News Daily News

FDA Approves Shockwave Intravascular Lithotripsy for Calcified Coronaries

Shelley Wood

February 16, 2021

News Conference News STS 2021

Surgeons More Likely to Stray From CABG Best Practices in Female Patients

February 03, 2021

News Daily News

Web-Like Structures in COVID-19 STEMI Clots May Offer New Drug Target

January 04, 2021

News Opinion Editor's Corner

Envision Change: A Different Future for Cardiology, Medicine, Research, and Health

Shelley Wood

December 29, 2020

News Daily News

William R. Hiatt, Giant of Vascular Medicine, Dies at 70

December 11, 2020

News Daily News

PCI at Ambulatory Centers: More Bleeding but No Penalty in Overall Outcomes

November 11, 2020

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

October 28, 2020

Presentation TCT 2020

TCT 183: Are There Any Procedural Differences Between Intra-Aortic Balloon Pump and Peripheral LVAD for Treatment of Cardiogenic Shock? A Clinical Comparison

Presenter: Mohammad Ansari

October 14, 2020

News Featured Fellow

Mahesh Anantha, MD

Yael L. Maxwell

October 12, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

September 24, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk